Anticancer activity of P,P-bis(2-methyl-1-aziridinyl)-N-2-pyrimidinylphosphinic amide (methylphosphazine) and related compounds.
D000230:Adenocarcinoma / Q000188:drug therapy; D000577:Amides; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001389:Azirines / Q000138:chemical synthesis / Q000627:therapeutic use*; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy; D008722:Methods; D051379:Mice; D010721:Phosphinic Acids / Q000138:chemical synthesis / Q000627:therapeutic use*; D011743:Pyrimidines; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D013852:Thiotepa / Q000627:therapeutic use
D000577:Amides; D000970:Antineoplastic Agents; D001389:Azirines; D010721:Phosphinic Acids; D011743:Pyrimidines; D003520:Cyclophosphamide; D013852:Thiotepa